Literature DB >> 19292450

Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues.

Hayato Ishikawa1, David A Colby, Shigeki Seto, Porino Va, Annie Tam, Hiroyuki Kakei, Thomas J Rayl, Inkyu Hwang, Dale L Boger.   

Abstract

Full details of the development of a direct coupling of catharanthine with vindoline to provide vinblastine are described along with key mechanistic and labeling studies. Following an Fe(III)-promoted coupling reaction initiated by generation of a presumed catharanthine radical cation that undergoes a subsequent oxidative fragmentation and diastereoselective coupling with vindoline, addition of the resulting reaction mixture to an Fe(III)-NaBH(4)/air solution leads to oxidation of the C15'-C20' double bond and reduction of the intermediate iminium ion directly providing vinblastine (40-43%) and leurosidine (20-23%), its naturally occurring C20' alcohol isomer. The yield of coupled products, which exclusively possess the natural C16' stereochemistry, approaches or exceeds 80% and the combined yield of the isomeric C20' alcohols is >60%. Preliminary studies of Fe(III)-NaBH(4)/air oxidation reaction illustrate a generalizable trisubstituted olefin scope, identify alternatives to O(2) trap at the oxidized carbon, provide a unique entry into C20' functionalized vinblastines, and afford initial insights into the observed C20' diastereoselectivity. The first disclosure of the use of exo-catharanthine proceeding through Delta(19',20')-anhydrovinblastine in such coupling reactions is also detailed with identical stereochemical consequences. Incorporating either a catharanthine N-methyl group or a vindoline N-formyl group precludes Fe(III)-promoted coupling, whereas the removal of the potentially key C16 methoxy group of vindoline does not adversely impact the coupling efficiency. Extension of these studies provided a total synthesis of vincristine (2) via N-desmethylvinblastine (36, also a natural product), 16-desmethoxyvinblastine (44) and 4-desacetoxy-16-desmethoxyvinblastine (47) both of which we can now suggest are likely natural products produced by C. roseus, desacetylvinblastine (62) and 4-desacetoxyvinblastine (59), as well as a series of key analogues bearing systematic modifications in the vindoline subunit. Their biological evaluation provided additional insights into the key functionality within the vindoline subunit contributing to the activity and sets the foundation on which further, more deep-seated changes in the structures of 1 and 2 will be explored in future studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19292450      PMCID: PMC2727944          DOI: 10.1021/ja809842b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  37 in total

1.  Total synthesis of (-)- and ent-(+)-vindorosine: tandem intramolecular Diels-Alder/1,3-dipolar cycloaddition of 1,3,4-oxadiazoles.

Authors:  Gregory I Elliott; Juraj Velcicky; Hayato Ishikawa; Yongkai Li; Dale L Boger
Journal:  Angew Chem Int Ed Engl       Date:  2006-01-16       Impact factor: 15.336

2.  Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids.

Authors:  N Langlois; F Guéritte; Y Langlois; P Potier
Journal:  J Am Chem Soc       Date:  1976-10-27       Impact factor: 15.419

Review 3.  Modifications in the "upper" velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities.

Authors:  J Fahy
Journal:  Curr Pharm Des       Date:  2001-09       Impact factor: 3.116

Review 4.  Anticancer therapy with novel tubulin-interacting drugs.

Authors:  M Kavallaris; N M Verrills; B T Hill
Journal:  Drug Resist Updat       Date:  2001-12       Impact factor: 18.500

5.  Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts.

Authors:  B T Hill; H H Fiebig; W R Waud; M F Poupon; F Colpaert; A Kruczynski
Journal:  Eur J Cancer       Date:  1999-03       Impact factor: 9.162

6.  Total synthesis of indole and dihydroindole alkaloids. IX. Studies on the synthesis of bisindole alkaloids in the vinblastine-vincristine series. The biogenetic approach.

Authors:  J P Kutney; T Hibino; E Jahngen; T Okutani; A H Ratcliffe; A M Treasurywala; S Wunderly
Journal:  Helv Chim Acta       Date:  1976-12-15       Impact factor: 2.164

7.  Directed biosynthesis of alkaloid analogs in the medicinal plant Catharanthus roseus.

Authors:  Elizabeth McCoy; Sarah E O'Connor
Journal:  J Am Chem Soc       Date:  2006-11-08       Impact factor: 15.419

8.  Syntheses and biological evaluation of vinblastine congeners.

Authors:  Martin E Kuehne; William G Bornmann; Istvan Markó; Yong Qin; Karen L LeBoulluec; Deborah A Frasier; Feng Xu; Tshilundu Mulamba; Carol L Ensinger; Linda S Borman; Anne E Huot; Christopher Exon; Fred T Bizzarro; Julia B Cheung; Susan L Bane
Journal:  Org Biomol Chem       Date:  2003-06-21       Impact factor: 3.876

9.  ALKALOIDS OF VINCA ROSEA LINN. (CATHARANTHUS ROSEUS G. DON). XXIV. VINASPINE, VINCATHICINE, ROVIDINE, DESACETYL VLB, AND VINAPHAMINE.

Authors:  G H SVOBODA; A J BARNES
Journal:  J Pharm Sci       Date:  1964-10       Impact factor: 3.534

10.  A note on the alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.). II. Catharanthine, lochnericine, vindolinine, and vindoline.

Authors:  M GORMAN; N NEUSS; G H SVOBODA; A J BARNES; N J CONE
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1959-04
View more
  87 in total

1.  Scalable total syntheses of N-linked tryptamine dimers by direct indole-aniline coupling: psychotrimine and kapakahines B and F.

Authors:  Timothy Newhouse; Chad A Lewis; Kyle J Eastman; Phil S Baran
Journal:  J Am Chem Soc       Date:  2010-05-26       Impact factor: 15.419

2.  Synthesis of a Potent Vinblastine: Rationally Designed Added Benign Complexity.

Authors:  Oliver Allemann; Manuela Brutsch; John C Lukesh; Daniel M Brody; Dale L Boger
Journal:  J Am Chem Soc       Date:  2016-07-01       Impact factor: 15.419

3.  The High Chemofidelity of Metal-Catalyzed Hydrogen Atom Transfer.

Authors:  Samantha A Green; Steven W M Crossley; Jeishla L M Matos; Suhelen Vásquez-Céspedes; Sophia L Shevick; Ryan A Shenvi
Journal:  Acc Chem Res       Date:  2018-11-08       Impact factor: 22.384

4.  Cycloadditions of 1,2,3-Triazines Bearing C5-Electron Donating Substituents: Robust Pyrimidine Synthesis.

Authors:  Christopher M Glinkerman; Dale L Boger
Journal:  Org Lett       Date:  2015-07-14       Impact factor: 6.005

5.  Total synthesis and evaluation of vinblastine analogues containing systematic deep-seated modifications in the vindoline subunit ring system: core redesign.

Authors:  Kristin D Schleicher; Yoshikazu Sasaki; Annie Tam; Daisuke Kato; Katharine K Duncan; Dale L Boger
Journal:  J Med Chem       Date:  2013-01-04       Impact factor: 7.446

6.  Hypervalent iodine(III)-promoted intermolecular C-C coupling of vindoline with β-ketoesters and related substrates.

Authors:  Travis C Turner; Kotaro Shibayama; Dale L Boger
Journal:  Org Lett       Date:  2013-02-19       Impact factor: 6.005

7.  A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20' urea derivatives.

Authors:  Erick K Leggans; Katharine K Duncan; Timothy J Barker; Kristin D Schleicher; Dale L Boger
Journal:  J Med Chem       Date:  2012-12-17       Impact factor: 7.446

8.  Divergent Total Syntheses of (-)-Pseudocopsinine and (-)-Minovincinine.

Authors:  Xianhuang Zeng; Vyom Shukla; Dale L Boger
Journal:  J Org Chem       Date:  2020-11-18       Impact factor: 4.354

9.  Mn-, Fe-, and Co-Catalyzed Radical Hydrofunctionalizations of Olefins.

Authors:  Steven W M Crossley; Carla Obradors; Ruben M Martinez; Ryan A Shenvi
Journal:  Chem Rev       Date:  2016-07-27       Impact factor: 60.622

10.  Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.

Authors:  John C Lukesh; Daniel W Carney; Huijun Dong; R Matthew Cross; Vyom Shukla; Katharine K Duncan; Shouliang Yang; Daniel M Brody; Manuela M Brütsch; Aleksandar Radakovic; Dale L Boger
Journal:  J Med Chem       Date:  2017-08-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.